利用电子健康技术在环境暴露舱中对油橄榄花粉过敏患者进行创新性症状评估方法

文献信息

中文摘要

引言： 本研究的背景和目的是什么？油橄榄（Olea）花粉症在南欧大片地区的患病率非常相关。本研究介绍并评估了一种在环境暴露舱（EEC）内使用电子健康技术的新方法，用于在马德里拉蒙-卡哈尔大学医院（RyCUH）评估油橄榄花粉过敏。主要目标是在临床上验证EEC中油橄榄花粉暴露的安全性和诊断性能，这是首次报道在该环境中使用橄榄花粉。
方法： 使用了哪些主要方法？在RyCUH开发了一个新的EEC，确保花粉分布可重复且环境条件稳定。该研究招募了20名志愿者：15名油橄榄花粉过敏个体和5名对照。使用REDCap这一电子数据采集工具，在EEC暴露前、暴露期间和暴露后收集患者报告的症状评分、哮喘相关数据和临床观察。PowerBI软件促进了对临床和技术参数的实时监测，以确保患者安全。
结果： 最重要的发现是什么？结果表明，15名过敏参与者中有12名（80%）在油橄榄花粉激发期间出现阳性反应，主要是鼻炎和结膜炎，少数出现轻度哮喘症状。对照组未观察到症状，证实了特异性。使用PowerBI能够立即评估症状严重程度，所有反应均得到及时处理。
结论： 得出的最重要结论是什么，结果的临床或研究相关性是什么？总之，本研究首次在EEC中进行油橄榄花粉激发，证明其是评估过敏患者的一种安全有效的方法。将REDCap和PowerBI整合用于EEC中，代表了一项重大进步，为油橄榄花粉过敏的症状评估和安全监测建立了一种新的精准医学工具，并促进了变态反应学的数字化转型。

英文摘要

INTRODUCTION: what is the context and aim of the study? The prevalence of Olea europaea (Olea) pollinosis in large areas of southern Europe is very relevant. This study introduces and assesses a novel approach using eHealth technologies within an environmental exposure chamber (EEC) to evaluate Olea pollen allergy at Ramón y Cajal University Hospital (RyCUH) in Madrid. The primary goal was to clinically validate the safety and diagnostic performance of Olea pollen exposure in an EEC, representing the first reported use of olive pollen in this setting.
METHODS: what were the principal methods used? A new EEC was developed at RyCUH, ensuring reproducible pollen distribution and stable environmental conditions. The study recruited 20 volunteers: 15 Olea pollen-allergic individuals and 5 controls. REDCap, an electronic data capture tool, was used to collect patient-reported symptom scores, asthma-related data, and clinical observations before, during, and after EEC exposure. PowerBI software facilitated real-time monitoring of clinical and technical parameters to ensure patient safety.
RESULTS: What are the most important findings? The results indicated that 12 of the 15 allergic participants (80%) experienced positive reactions during the Olea pollen challenge, primarily rhinitis and conjunctivitis, with a few developing mild asthma symptoms. No symptoms were observed in the control group, confirming specificity. The use of PowerBI enabled immediate assessment of symptom severity, and all reactions were promptly managed.
CONCLUSIONS: What is the most important conclusion drawn, and what is the clinical or research relevance of the results? In conclusion, this study presents the first Olea pollen challenge in an EEC, demonstrating it to be a safe and effective method for evaluating allergic patients. The integration of REDCap and PowerBI for the in an EEC, represents a significant advancement, establishing a new precision medicine tool for symptom assessment and safety monitoring in Olea pollen allergy and contributing to the digital transformation of allergology.